← All policies
TELEHEALTH & TREATMENT CONSENT

Telehealth & Treatment Consent

Peptide Therapy Consent

The risks, benefits, and regulatory status of compounded peptide therapy.

What I am agreeing to

I am choosing to receive peptide therapy prescribed by Jason D. Wright, D.O., through a telehealth evaluation. My medications are prepared for me individually by a licensed 503A compounding pharmacy and shipped to me directly.

Compounded medications

Off-label and limited evidence

Telehealth

General risks of injectable peptide therapy

My responsibilities

Pregnancy, fertility, and athletics

Financial

My right to stop

I may stop treatment at any time. I understand that stopping may reverse any benefit I have gained, and that I should tell the practice so my plan can be adjusted safely.

Product-specific addenda (GLP-1 medications, Melanotan II, IGF-1 LR3, ibutamoren and the ghrelin-receptor blends, methylene blue, hCG, enclomiphene and clomiphene, kisspeptin, PT-141, and the TB-500 blends) are reviewed and signed with your physician for the specific products you are prescribed.

← Back to all policies